Peers of Matinas BioPharma Holdings Inc (MTNB)
Side-by-side comparison
Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
805.82x
As of Mar 28, 2024
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Mar 28, 2024 | 805.82x |
| Mar 27, 2024 | 862.02x |
| Mar 26, 2024 | 849.53x |
| Mar 25, 2024 | 862.91x |
| Mar 22, 2024 | 826.64x |
| Mar 21, 2024 | 791.55x |
| Mar 20, 2024 | 856.37x |
| Mar 19, 2024 | 843.88x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison